Cel-Sci proposes direct public offering

Cel-Sci Corp. (NYSE-M:CVM), Vienna, Va. Business: Cancer, Infectious Date announced: 2016-05-18 Type: Direct public offering To be raised: $5 million Shares: 10 million Price prior: $0.54 Shares outst...